5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin

Metabolite details

Identifier

FEEKFEKCXIDMIS-UHFFFAOYSA-N

InChI Key

FEEKFEKCXIDMIS-UHFFFAOYSA-N

IUPAC name

5-(3,4-dihydroxycyclohexa-1,5-dien-1-yl)-5-phenylimidazolidine-2,4-dione

Preferred name

5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin

INN name

—

Synonym

—

ChEBI

CHEBI:166540

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• Control_0d_vs_Treatment_180d
• Control_vs_BP3_Low_Concentration